PATENT CLAIM ANALYSIS

Application Number: 15757166
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["514", "266200"]

Abstract:
The present disclosure provides a method of treating a biliary duct cancer, such as cholangiocarcinoma, by administering a therapeutically effective amount of a compound of formula (I), in particular Varlitinib, an enantiomer thereof or a pharmaceutically acceptable salt of any one of the same.

Claim (Index 1):
A method of treating a biliary duct cancer by administering a therapeutically effective amount of a compound of formula (I): an enantiomer thereof or a pharmaceutically acceptable salt of any one of the same; wherein the biliary duct cancer is gallbladder cancer or cholangiocarcinoma; and wherein the cholangiocarcinoma is located in an intrahepatic bile duct, left hepatic duct, right hepatic duct, common hepatic duct, cystic duct, common bile duct, Ampulla of Vater or any combinations thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.275
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15757133', '15757189', '14776552', '12763991', '11100433']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.703648014724809
- 35 USC 102 Novelty (BERT): 0.5451044524487854
- Combined Prediction Score: 0.6877936584972066
- Mean Citation Score: 266.876084
- Max Citation Score: 392.1929
- Similarity Product: 295.06393321301937

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test